期刊文献+

骨质疏松症国内外药物治疗的研究现状 被引量:36

Research status of drug therapy for osteoporosis at home and abroad
原文传递
导出
摘要 骨质疏松症是一种常见骨病,其并发症骨折的发生风险高。骨质疏松症的治疗药物主要包括骨矿化促进剂、骨吸收抑制药、骨形成促进剂、其他机制类药物和中药等。本文旨在对骨质疏松症国内外药物治疗现状加以综述。 Osteoporosis is a common bone disease with high risk of fracture complications.Osteoporosis treatment drugs mainly include bone mineralization promoters,bone resorption inhibitors,bone formation promoters,other mechanism drugs and traditional Chinese medicine.This article aims to review the current situation of drug therapy for osteoporosis at home and abroad.
作者 祝晓雨 张伟光 赵志刚 ZHU Xiao-yu;ZHANG Wei-guang;ZHAO Zhi-gang(Department of Pharmacy,Beijing Tiantan Hospital Affiliated to Capital Medical University,Beijing 100050,China;Department of Pharmacy,Beijing Chaoyang Hospital Affiliated to Capital Medical University,Beijing 100043,China)
出处 《中国临床药理学杂志》 CAS CSCD 北大核心 2020年第5期588-592,共5页 The Chinese Journal of Clinical Pharmacology
关键词 骨质疏松症 进展 指南 药物治疗 osteoporosis progress guide drug treatment
  • 相关文献

参考文献7

二级参考文献91

  • 1王宏,王玲,李建军,刘玉槐,隋福革.鹿茸健骨胶囊治疗原发性骨质疏松症的临床疗效观察[J].中国骨质疏松杂志,2004,10(3):344-346. 被引量:4
  • 2Eriksen EF, Diez-Perez A, Boonen S. Update on long-term treatment with bisphosphonates for postmenopausal osteoporosis: A systematic review[J]. Bone, 2014, 58: 126-135.
  • 3Joann V, Pinkerton, Semara Thomas, et al. Osteoporosis treatment and prevention for postmenopausal women: current and future therapeutic options[J]. Clin Obstet Gynecol, 2013, 56(4): 711-721.
  • 4Ractmer TD, Khosla S, Hofoauer LC. Osteoporosis: now and the future[J]. Lancet, 2011, 377(9773): 1276-1287.
  • 5Khosla S, Bilezikian JP, Dempster DW, et al. Benefits and risks of bisphosphonate therapy for osteoporosis[J]. J Clin Endoerinol Metab, 2012, 97(7): 2272-2282.
  • 6Black DM, Cummings SR, Karpf DB, et al. Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures. Fracture Intervention Trial Research Group[J]. Lancet, 1996, 348(9041): 1535-1541.
  • 7Black DM, Delmas PD, Eastell IL et al. Once-yearly zoledronic acid for treatment ofpostmenopausal ostcoporosis[J]. N Engl J Med, 2007, 356(18): 1809-1822.
  • 8Watts NB, Diab DL. Long-term use of bisphosphonates in osteoporosis[J]. J Clin Endorinol Metab, 2010, 95(4): 1555-1565.
  • 9Rossouw JE, Anderson GL, Prentice RL, et al. Writing Group for the Women's Health Initiative Investigators. Risk and benefits of estrogen plus progestin in healthy postmenopausal women[J]. JAVIA, 2002, 288(3): 321- 333.
  • 10Ettinger B, Black DM, Mitlak BH, et al. Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: results from a 3-year randomized clinical trial. Multiple Outcomes of Raloxifene Evaluation(MORE) Investigators[J]. JAMA, 1999, 282(7): 637-645.

共引文献338

同被引文献450

引证文献36

二级引证文献127

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部